Jun 21, 2009 - 11:58 am
I just read in Bottom Line Personal (volume 30, number 13, July 1,2009) that there is an experimental vaccine being tested that "...may improve the survival of men with advanced disease."
"If approved by the FDA, Provenge could become an added treatment for late-stage cancer."
This was reported to Bottom Line by Eric J. Small, MD, cancer specialist, University of California, San Francisco, and chief, division of hematology and oncology, UCSF Helen Diller Family Comprehensive Cancer Center.